GSK and Viome expand microbiome-based cancer therapeutics deal
GlaxoSmithKline (GSK) are to expand on an existing collaboration with Viome that looks into links between the gut microbiome and certain cancers.
Source: nutraingredients.com
Stay updated with breaking news from Metatranscriptomic Sequencing Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GlaxoSmithKline (GSK) are to expand on an existing collaboration with Viome that looks into links between the gut microbiome and certain cancers.